Directs the Secretary of Health and Human Services to collect a user fee from each manufacturer of a food, drug, device, biological product, or animal drug for which a followup reinspection is required to ensure correction of a violation of a Good Manufacturing Practices requirement under the Federal Food, Drug, and Cosmetic Act found by the Secretary during the initial inspection of the manufacturer.